MX2009008754A - Novel antibodies against igf-ir. - Google Patents

Novel antibodies against igf-ir.

Info

Publication number
MX2009008754A
MX2009008754A MX2009008754A MX2009008754A MX2009008754A MX 2009008754 A MX2009008754 A MX 2009008754A MX 2009008754 A MX2009008754 A MX 2009008754A MX 2009008754 A MX2009008754 A MX 2009008754A MX 2009008754 A MX2009008754 A MX 2009008754A
Authority
MX
Mexico
Prior art keywords
antibodies against
novel antibodies
against igf
antibodies
antigen binding
Prior art date
Application number
MX2009008754A
Other languages
Spanish (es)
Inventor
Paul Andrew Hamblin
Jonathan Henry Ellis
Alan Peter Lewis
Michael Neil Burden
Radha Shah
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0702888.9A external-priority patent/GB0702888D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MX2009008754A publication Critical patent/MX2009008754A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Abstract

The present invention relates to antibodies or antigen binding fragments thereof which specifically binds to IGF-1 R, specifically hlGF-1 R. Also disclosed are antibody preparations comprising antibodies or antigen binding fragments of the invention. Methods of producing such antibodies or antigen binding fragments and uses thereof are also included within the scope of the present invention.
MX2009008754A 2007-02-14 2008-02-12 Novel antibodies against igf-ir. MX2009008754A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0702888.9A GB0702888D0 (en) 2007-02-14 2007-02-14 Novel Antibodies
US95321007P 2007-08-01 2007-08-01
PCT/EP2008/051655 WO2008098917A2 (en) 2007-02-14 2008-02-12 Novel antibodies against igf-ir

Publications (1)

Publication Number Publication Date
MX2009008754A true MX2009008754A (en) 2009-11-02

Family

ID=42025950

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008754A MX2009008754A (en) 2007-02-14 2008-02-12 Novel antibodies against igf-ir.

Country Status (5)

Country Link
JP (1) JP2010518140A (en)
KR (1) KR20090114449A (en)
EA (1) EA200900991A1 (en)
MX (1) MX2009008754A (en)
PE (1) PE20090107A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2545401C2 (en) 2010-02-23 2015-03-27 Санофи Anti-integrin alpha-2 antibodies and using them
UY33578A (en) 2010-08-31 2012-03-30 Sanofi Sa PEPTIDE PEPTIDE OR COMPLEX THAT JOINS INTEGRINE TO (ALPHA) AND METHODS AND USES THAT INVOLVE THE SAME
US10538575B2 (en) * 2011-12-15 2020-01-21 The Royal Institution For The Advancement Of Learning/Mcgill University Soluble IGF receptor Fc fusion proteins and uses thereof
CA3002741A1 (en) * 2015-10-23 2017-04-27 Apogenix Ag Single-chain gitr-receptor agonist proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2433800C (en) * 2001-01-05 2016-09-13 Pfizer Inc. Antibodies to insulin-like growth factor i receptor
US8034904B2 (en) * 2002-06-14 2011-10-11 Immunogen Inc. Anti-IGF-I receptor antibody
US7538195B2 (en) * 2002-06-14 2009-05-26 Immunogen Inc. Anti-IGF-I receptor antibody
CA2524305C (en) * 2003-05-01 2015-12-08 Imclone Systems Incorporated Fully human antibodies directed against the human insulin-like growth factor-1 receptor
WO2005058967A2 (en) * 2003-12-16 2005-06-30 Pierre Fabre Medicament Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof
FR2873699B1 (en) * 2004-07-29 2009-08-21 Pierre Fabre Medicament Sa NOVEL ANTI-IGF ANTIBODIES IR RT USES THEREOF
WO2007000328A1 (en) * 2005-06-27 2007-01-04 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof
FR2888850B1 (en) * 2005-07-22 2013-01-11 Pf Medicament NOVEL ANTI-IGF-IR ANTIBODIES AND THEIR APPLICATIONS

Also Published As

Publication number Publication date
PE20090107A1 (en) 2009-03-20
KR20090114449A (en) 2009-11-03
JP2010518140A (en) 2010-05-27
EA200900991A1 (en) 2010-02-26

Similar Documents

Publication Publication Date Title
WO2008098917A3 (en) Novel antibodies against igf-ir
MX2010001237A (en) Novel antibodies.
WO2009052400A8 (en) Antibodies that bind to mammalian ngal and uses thereof
WO2010136311A3 (en) Compositions and methods for antibodies targeting complement protein c3b
PH12015501848A1 (en) Binding agents
NZ597023A (en) Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same
WO2006113546A3 (en) Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
UA92505C2 (en) Anti-cd3 antibody formulations
MY174493A (en) Binding agents
WO2007116360A3 (en) Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof
AU2009260320A8 (en) Antibodies to IL-6 and their uses
UA106070C2 (en) Antibody that specifically binds to egfr and her3
MY194997A (en) Anti-ccr7 antibody drug conjugates
NZ592432A (en) Antibodies that specifically block the biological activity of a tumor antigen Kidney associated antigen 1 (KAAG1)
WO2012027721A3 (en) Antibodies to matrix metalloproteinase 9
TW200510459A (en) RG1 antibodies and uses thereof
MX2010006767A (en) Hepatitis c virus antibodies.
MX2009009926A (en) Monoclonal human tumor-specific antibody.
MX2009004167A (en) Antibodies that bind cxcr7 epitopes.
WO2011004028A3 (en) Tlr3 binding agents
MX2022000325A (en) Dll3-targeting antibodies and uses thereof.
AU2018338322A1 (en) A33 antibody compositions and methods of using the same in radioimmunotherapy
NZ629553A (en) Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof
UA99602C2 (en) Antibody that specifically binds to jam-a, capable of inhibiting the proliferation of tumor cells
WO2008151819A3 (en) Treatment of tumors using specific anti-l1 antibody